1. Journal searcher
  2. Top 15 journals in Biochemistry
  3. Metabolic Brain Disease
Metabolic Brain Disease

ISSN: 0885-7490

Journal Home

Journal Guideline

Metabolic Brain Disease Q2 Unclaimed

Springer United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Metabolic Brain Disease serves as a forum for the publication of outstanding basic and clinical papers on brain diseases, including both human and animal studies. Topics include, but are not limited to, stroke, traumatic brain injury, myelin disorders, epilepsy, multiple sclerosis, toxic encephalopathies, genetic diseases affecting the brain, alcohol and brain metabolism, neuroendocrinopathies, viral and nonviral encephalitides, nutritional disorders affecting the brain, diseases affecting neurotransmitters, Alzheimer's disease, Parkinson’s disease, amyotrophic lateral sclerosis and aging. The journal publishes papers on the fundamental pathogenesis of these disorders and on related experimental and clinical techniques and methodologies. Metabolic Brain Disease is directed to neuroscientists, psychiatrists, neurologists, pathologists, and others involved in the research and treatment of a broad range of brain disorders. Metabolic Brain Disease will consider Full Research Papers, Short Communications, Review Articles and Editorials. The journal is committed to high standards of presentation. Please contact the Editor to discuss the suitability of topics. 100% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again It has an SJR impact factor of 0,941.

Metabolic Brain Disease focuses its scope in these topics and keywords: brucei, chronic, connectivity, imaging, memory, alzheimer’s, biochemical, blocker, brain, cellular, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Scopus WOS
Categories: Biochemistry (Q2) Neurology (clinical) (Q2) Cellular and Molecular Neuroscience (Q3)
Price

3190 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Metabolic Brain Disease

0,941

SJR Impact factor

83

H Index

121

Total Docs (Last Year)

647

Total Docs (3 years)

8467

Total Refs

2572

Total Cites (3 years)

640

Citable Docs (3 years)

3.73

Cites/Doc (2 years)

69.98

Ref/Doc

Comments

No comments ... Be the first to comment!
User post comment
* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Non-coding RNA Q2
Metabolites Q2
Proteomics Q2
International Journal of Biochemistry and Cell Biology Q2
Peptides Q2
Compare this journals

Aims and Scope

brucei, chronic, connectivity, imaging, memory, alzheimer’s, biochemical, blocker, brain, cellular, cerebral, cirrhosis, deficits, diffusion, disease, dual, energetic, evidence, functional, glutamate, gutliverbrain, hippocampal, implications, inhibition, inhibitory, ischemiainduced, mediatorsprevention, modelenhancement, modelglutamateinduced, mouse, mr, mtorcmtorc, multimodal, nmda, omega,

FAQS

What is the impact factor of Metabolic Brain Disease?

In Country of Paypers you can find Impact factor and other metrics to help you decide on a Journal.